299 related articles for article (PubMed ID: 6343038)
1. Immunogenicity of human insulin (Novo) or pork monocomponent insulin in HLA-DR-typed insulin-dependent diabetic individuals.
Schernthaner G; Borkenstein M; Fink M; Mayr WR; Menzel J; Schober E
Diabetes Care; 1983; 6 Suppl 1():43-8. PubMed ID: 6343038
[TBL] [Abstract][Full Text] [Related]
2. [HLA typing and insulin antibody production in insulin-dependent diabetics].
Bruni B; Barolo P; Gadaleta G; Gamba Ansaldi S; Grassi G; Zerbinati A; Molinatti M; Salvetti E
Ann Osp Maria Vittoria Torino; 1984; 27(7-12):185-213. PubMed ID: 6443704
[TBL] [Abstract][Full Text] [Related]
3. Insulin antibodies in diabetics receiving a single type of insulin.
Mincu I; Cheţa D
Med Interne; 1982; 20(1):9-13. PubMed ID: 6765628
[TBL] [Abstract][Full Text] [Related]
4. In vitro lymphocyte proliferation response to therapeutic insulin components. Evidence for genetic control by the human major histocompatibility complex.
Mann DL; Mendell N; Kahn CR; Johnson AH; Rosenthal A
J Clin Invest; 1983 Sep; 72(3):1130-8. PubMed ID: 6411767
[TBL] [Abstract][Full Text] [Related]
5. Comparative trials with monocomponent (MC) and monospecies (MS) pork insulins in the treatment of diabetes mellitus. Influence on antibody levels, on insulin requirement and on some complications.
Andreani D; Iavicoli M; Tamburrano G; Menzinger G; Maltarello C
Horm Metab Res; 1974 Nov; 6(6):447-54. PubMed ID: 4476720
[No Abstract] [Full Text] [Related]
6. [The antigenicity of various new chromatographically purified depot insulin preparations].
Graber D; Fankhauser S
Schweiz Med Wochenschr; 1978 Nov; 108(46):1807-9. PubMed ID: 715418
[TBL] [Abstract][Full Text] [Related]
7. [Purity and antigenicity of the new insulin preparations].
Fankhauser S
Schweiz Med Wochenschr; 1976 Sep; 106(36):1218-25. PubMed ID: 996531
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of the antibody anti-insulin titer using Christiansen's radioimmunoelectrophoresis in clinical diabetology].
Bruni Bocher K; Castellazzi R; D'Adda A; Gamba S; Giolitti A; Rittatore R; Turco GL; Bruni B
Ann Osp Maria Vittoria Torino; 1975; 18(1-6):26-52. PubMed ID: 1242089
[TBL] [Abstract][Full Text] [Related]
9. [Clinical experiences with monocomponent insulins].
Bruni Bocher K; Giolitti A; Turco GL; Benedetto P; Bruni B
Minerva Med; 1975 Mar; 66(19):909-30. PubMed ID: 1124144
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of efficacy and safety of human insulin (Novo) in the treatment of insulin-dependent diabetes mellitus: a double-blind, multicenter clinical trial.
Karam J; Brink S; Clements R; Miller L; Raskin P
Diabetes Care; 1983; 6 Suppl 1():56-60. PubMed ID: 6343041
[TBL] [Abstract][Full Text] [Related]
11. [Factors affecting the antigenicity of exogenous insulin in diabetics].
Penchev II; Taneva T; Ditsov S; Andreev D
Vutr Boles; 1985; 24(1):113-9. PubMed ID: 3895740
[TBL] [Abstract][Full Text] [Related]
12. Transfer from purified porcine insulins to semisynthetic human insulins decreases insulin antibodies and circulating immune complexes in diabetic children and adolescents. A two-year follow-up.
Dorchy H; Duchateau J; Bosson D; D'Hooge D
Diabete Metab; 1989; 15(3):107-10. PubMed ID: 2668052
[TBL] [Abstract][Full Text] [Related]
13. Comparison of porcine insulin and human insulin (Novo) using the glucose-controlled insulin infusion system, glucose-insulin dose-response curves, and the outpatient effectiveness of human insulin (Novo) in insulin-dependent diabetes.
Charles MA; Szekeres A; Staten M; Worcester B; Walsh KM
Diabetes Care; 1983; 6 Suppl 1():29-34. PubMed ID: 6343034
[TBL] [Abstract][Full Text] [Related]
14. Lymphocyte proliferation as a test of the immune response to insulin in diabetics.
Kurtz AB; Di Silvio L; Lydyard P
Diabetes Res; 1985 Jul; 2(4):175-8. PubMed ID: 3910325
[TBL] [Abstract][Full Text] [Related]
15. Insulin-specific IgE in serum of 67 diabetic patients against human insulin (Novo), porcine insulin, and bovine insulin. Four case reports.
Falholt K; Hoskam JA; Karamanos BG; Süsstrunk H; Viswanathan M; Heding LG
Diabetes Care; 1983; 6 Suppl 1():61-5. PubMed ID: 6343042
[TBL] [Abstract][Full Text] [Related]
16. The immunogenicity of insulin preparations.
Chance RE; Root MA; Galloway JA
Acta Endocrinol Suppl (Copenh); 1976; 205():185-98. PubMed ID: 793278
[TBL] [Abstract][Full Text] [Related]
17. [Long-term clinical results with monocomponent insulin (MC lente) in infantile and juvenile diabetes].
Bruni KB; Neirotti R; Albonico G; Gamba S; Regis G; D'Adda A; Soldano E; Bruni B
Ann Osp Maria Vittoria Torino; 1976; 19(16):7-26. PubMed ID: 1027349
[TBL] [Abstract][Full Text] [Related]
18. Coeliac disease and diabetes mellitus: a study of 24 patients with HLA typing.
Shanahan F; McKenna R; McCarthy CF; Drury MI
Q J Med; 1982; 51(203):329-35. PubMed ID: 6755530
[TBL] [Abstract][Full Text] [Related]
19. Reduction in insulin antibodies 42 months after transfer from porcine to human monocomponent insulins.
Virgili F; Frigato F; Magnanini PG; Coronel GA; Iavicoli M
Diabetes Res; 1988 Sep; 9(1):19-20. PubMed ID: 3071441
[TBL] [Abstract][Full Text] [Related]
20. Behaviour of insulin antibodies in diabetics treated with different insulins.
Mincu I; Cheţa D; Ionescu-Tîrgovişte C; Mirodon Z; Sîntu E
Med Interne; 1980; 18(4):347-52. PubMed ID: 7006044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
